Go to Top

2021-2022 Leadership Team

Marc Carrier, MD, MSc, FRCPC

Dr. Marc Carrier is Head of the Division of Hematology at The Ottawa Hospital, a Professor in the Faculty of Medicine, Department of Medicine and Senior Scientist in the Clinical Epidemiology Program of The Ottawa Hospital Research Institute. He holds a Tier 1 Research Chair in Venous Thromboembolism and Cancer from the Faculty of Medicine at the University of Ottawa.

Follow Dr. Carrier on Twitter at @MarcCarrier1

Lana Castellucci, MD, FRCPC, MSc

Vice President
Co-Chair, Social Media

Dr. Lana Castellucci is an Associate Professor in the Faculty of Medicine at the University of Ottawa, and a Scientist at The Ottawa Hospital Research Institute (OHRI). She is Vice-President of Thrombosis Canada, a national organization promoting patient education and improved outcomes for patients with venous thrombosis. She is an active member of the CanVECTOR (Canadian Venous Thromboembolism Clinical Trials and Outcomes Research) Network, and is a recipient of the University of Ottawa Tier 2 Research Chair in Thrombosis and Anticoagulation Safety and the Heart and Stroke Foundation of Canada National New Investigator Award.

Dr. Castellucci’s clinical and research interests are focused on the prevention, diagnosis and management of anticoagulant-related bleeding and venous thromboembolism. She is the Principal Investigator of peer-reviewed international clinical trials (funded by the Canadian Institutes of Health Research) Comparison of Bleeding Risk between Rivaroxaban and Apixaban (COBRRA) in patients with acute venous thromboembolism and atrial fibrillation.

Follow Dr. Castellucci on Twitter at @LanaCastellucci.

Peter Gross, MD, MSc, FRCPC
Research/CanVector Liaison


Dr. Peter L. Gross obtained his MSc in Biochemistry and his MD from the University of Toronto. He did his Core Internal Medicine training in Toronto. He did his Hematology/Oncology Fellowship at Beth Israel Deaconess Medical Center, a Harvard Teaching Hospital. He was Clinician Scientist in the Department of Medicine at St Michael’s Hospital in Toronto from 2003 to 2007. He is currently an Associate Professor in the Division of Hematology and Thromboembolism at McMaster University, Hamilton and the Head of the Clinical Thrombosis Service at Hamilton Health Sciences.

Dr. Gross’s basic science laboratory at the Thrombosis and Atherosclerosis Research Institute (TaARI) focuses on models of thrombosis and hemostasis, and biomarkers for these conditions. Dr. Gross is also is involved in various capacities in clinical trials in venous thrombosis.

Deborah Siegal, MD, MSc, FRCPC

Dr. Siegal graduated from Queen’s University School of Medicine in 2009. She completed Internal Medicine and Hematology training at McMaster University. She holds Master of Science degrees in Pharmacology (University of Toronto) and Health Research Methodology (McMaster University).

Dr. Siegal is currently an Associate Professor in the Department of Medicine at the University of Ottawa and Associate Scientist at the Ottawa Hospital Research Institute. Her primary research interest is improving the safety of anticoagulant therapy including optimizing the management of anticoagulant-related bleeding complications, restarting anticoagulants after bleeding, perioperative management of anticoagulants, and antithrombotic therapies for ischemic stroke in patients with cancer. She has published over 75 articles in peer-reviewed journals including The New England Journal of Medicine, Circulation, Blood and Journal of Thrombosis and Haemostasis. Her research has been published in high-impact journals including The New England Journal of Medicine, Circulation, Annals of Internal Medicine, Blood and Journal of Thrombosis and Haemostasis.

James Douketis, MD, FRCPC


Dr. James Douketis is Staff Physician in the Department of Medicine, Divisions of Thromboembolism, Hematology and General Internal Medicine at St. Joseph’s Healthcare Hamilton, and Professor of Medicine at McMaster University.

He received his Doctor of Medicine degree and completed his residency in Internal Medicine at the University of Toronto. He then completed a thrombosis fellowship at McMaster University.

Dr. Douketis’ research interests include perioperative antithrombotic therapy, prognosis of patients with venous thromboembolism, hormonal therapy and thrombosis, prevention of venous thrombosis in medical patients, and clinical practice guideline development.

Dr. Douketis has been a member of Thrombosis Canada since 2003 and holds executive positions with the International Society on Thrombosis and Haemostasis (ISTH) and the International Thrombosis and Cancer Initiative (ITAC). He is Editor-in-Chief of the Canadian Journal of General Internal Medicine, Deputy Editor of Annals of Internal Medicine ACP Journal Club, and Associate Editor of Thrombosis and Hemostasis.

Sudeep Shivakumar, MD, FRCPC
Board Member


Dr. Shivakumar is an associate professor in the Department of Medicine at Dalhousie University, and a clinical hematologist at the Nova Scotia Health Authority in Halifax, Canada.  He is currently the Director of Thrombosis and Anticoagulation and the Division Head of Hematology at Dalhousie University.

He received his Doctor of Medicine degree at Queen’s University in Kingston, Ontario, and subsequently completed his Internal Medicine and Hematology residencies at Dalhousie University. He then went on to complete a clinical fellowship in Thrombosis at the University of Ottawa and a Masters of Public Health degree from the Harvard School of Public Health.

He is currently a member of the Executive Committee of Thrombosis Canada, and a platform co-chair of the Venous Thromboembolism Clinical Trials Organization (VECTOR) research group.  He has received CIHR funding for the upcoming EPCAT3 study looking at post-hip and knee replacement VTE prophylaxis.

Vera Dounaevskaia, MD, FRCPC, FACP
Fundraising Lead

Dr. Dounaevskaia is an Assistant Professor of Medicine at University of Toronto and attending General Internal Medicine physician at St. Michael’s Hospital. She is a Director of Ambulatory GIM clinic at St. Michael’s Hospital, as well as current interim GIM division head director.  She completed her training in Internal Medicine and General Internal Medicine at the University of Toronto in 2010. She pursued additional training in Thromboembolism and Hemostasis at McMaster University from 2010-2012. Dr. Dounaevskaia leads Quality Improvement for in-hospital VTE prophylaxis at St. Michael’s hospital, as well as attends in VTE/Thrombosis clinic with wide range of clinical interests within the field.


David Airdrie
Executive Director

David Airdrie

David Airdrie is an experienced leader and manager. David comes to Thrombosis Canada with the expertise required to grow and support the organization as it looks to the future. With over 25 years in the health care field, he brings experience in strategic development, knowledge translation, medical communications, community engagement and execution that will support Thrombosis Canada as it builds its capacity. His experience includes leading development of a broad range of medical education and communication programs in many therapeutic areas including thrombosis, developing innovative digital programs and developing strategic communications plans for many health care organizations.

Vicky Tagalakis, MD, FRCPC, MSC
Co-Chair of Clinical Guides Committee

Dr. Vicky Tagalakis is an Associate Professor of Medicine at McGill University and an attending in the Department of Medicine of the Jewish General Hospital. She is Director of the Division of General Internal Medicine at McGill University. She completed an MSc in Epidemiology and Biostatistics at McGill University in 2003 and is a Research Scientist in the Centre of Epidemiology and Community of Studies, Lady Davis Institute for Medical Research, Jewish General Hospital. She holds several peer-reviewed grants. She is Co-Lead of the Quality Improvement Platform of CanVECTOR), a CIHR funded national research network on venous thromboembolism (VTE).

Dr. Tagalakis’ principal research interests focus primarily on VTE and VTE-related outcomes primarily in cancer patients. She has expertise in research methodology including pharmacoepidemiology pertaining to thrombosis-related analyses of large administrative databases. She has been awarded numerous peer-reviewed research grants from national and provincial funding agencies, and has published extensively in the field of venous thrombosis.

Andre Roussin, MD, CSPQ, FRCPC
Co-Chair of Clinical Guides Committee

Dr. André Roussin completed his medical training in Montreal, including a specialty in Internal Medicine. He did a number of post-doctoral studies in non-invasive techniques in vascular diseases at the University of Iowa (Iowa City, Iowa) and at the University of Hamilton (Hamilton, Ontario) as well as research in Raynaud’s phenomenon at the UCSF in San Francisco.  Dr. Roussin is associate professor of the Department of Medicine. He has headed the Vascular Lab, Notre-Dame Hospital, University of Montreal (CHUM) from 1985 to the transfer at the CHUM in 2017 and is now co-responsible of the Doppler lab in the CHUM department of radiology. Dr. Roussin has been involved in the publication of numerous abstracts, articles and book chapters. He is a frequent presenter at meetings and symposia. Dr. Roussin main areas of interest are the investigation and treatment modalities of arterial, venous and cerebro-vascular diseases. Dr Roussin is Past-President of Thrombosis Canada and Past-President, Secretary-Treasurer and Co-founder of the Quebec Society of Vascular Sciences (QSVS/SSVQ).

Miriam Kimpton, MD, MSc, FRCPC
Chair of Fellowship & Training Committee

Dr. Kimpton completed a Hematology residency at the University of Toronto and the Adult Thrombosis Medicine fellowship at the University of Ottawa, funded by the CanVECTOR Research Training Award and the Thrombosis Canada-CanVECTOR Research Fellowship. She currently works as a Thrombosis physisian at The Ottawa Hospital, an Associate Scientist in the Clinical Epidemiology Program of the Ottawa Hospital Research Institute, and an Assistant Professor in the Faculty of Medicine at the University of Ottawa.  Dr. Kimpton’s research interests include prophylaxis and treatment of cancer-associated thrombosis, with a special focus on myeloproliferative neoplasms.


Vinai Bhagirath, MD, FRCP
Chair of Continuing Professional Development

Dr. Vinai Bhagirath is a Hematologist and Thrombosis physician working at Hamilton Health Sciences, and Assistant Professor of Medicine at McMaster University.

He received his MD degree and completed his residency in Internal Medicine at the University of Western Ontario, then went on to Hematology residency at McMaster University. He continued at McMaster to obtain an MSc and to pursue clinical research training.

Dr. Bhagirath is the Director of McMaster’s Adult Thrombosis Medicine training program. His research interests include optimal dosing of anticoagulant medications, and eHealth as a means for knowledge translation. He is grateful for the opportunity to serve as Chair of Thrombosis Canada’s Continuing Professional Development committee since 2020.

Anil Chopra, MD, FRCP
Chair of Emergency Medicine

ChopraDr. Anil Chopra is the Division Director of Emergency Medicine and Associate Professor in the Department of Medicine at the University of Toronto. He is also the Vice President of Medical Affairs at University Health Network in Toronto.

He received his Doctor of Medicine degree and completed his residency in Emergency Medicine at the University of Toronto. He is also a Diplomate of the American Board of Emergency Medicine.

Dr. Chopra’s clinical and research interests are in the management of venous and arterial thrombosis. He has contributed several publications in the area of thromboembolism. He has been a member of Thrombosis Canada since 2012.

Susan Jenkins, RN(EC), NP
Co-Chair, Patients and Family Committee

Susan Jenkins is a Nurse Practitioner in the UHN Thrombosis and Hemostasis Program and an Adjunct Lecturer at the Bloomberg Faculty of Nursing at the University of Toronto.

She received her undergraduate degree in Nursing from Western University and a Masters in Nursing with completion of the Adult Nurse Practitioner certificate from the University of Toronto.

Susan has a special interest in thrombosis treatment and anticoagulation management, health literacy, patient education and self care. She is currently leading an interdisciplinary team working to develop an adult warfarin patient self management program at UHN.

Tammy J Bungard, BSP, PharmD
Co-Chair, Patients and Family Committee

Dr. Bungard is a Professor of Medicine within the Division of Cardiology at the University of Alberta.

She received her undergraduate pharmacy degree at the University of Saskatchewan and her Doctor of Pharmacy at Wayne State University in Detroit, Michigan. She then completed a research fellowship at the University of Alberta, where she implemented, and servers as the Director, the Anticoagulation Management Service.

Dr. Bungard’s research themes encompass clinical knowledge of the use of antithrombotic therapies, both patient specific clinical management strategies and the development of clinical reviews/tools for healthcare providers, as well as scopes of practice within healthcare systems.

Co-Chair, Social Media Committee

Eddy Lang is a Professor and Department Head for Emergency Medicine at Cumming School of Medicine- University of Calgary and Alberta Health Services, Calgary Zone. He is also the Scientific Director of the Emergency Strategic Clinical Network (ESCN), Alberta Health Services. His areas of interest are knowledge translation, evidence-based medicine, and operations research. Dr. Lang has served as the chair of the CAEP Leadership Committee from 2017 to 2020. Dr. Lang is also an award-winning educator having received recognition at both the university, national and international levels.  He also serves as Senior Editor for the Canadian Journal of Emergency Medicine, Associate Editor for both ACP Journal Club and the International Journal of Emergency Medicine. In addition, he is a member of the Canadian Task Force on Preventive Health Care (CTFPHC). Dr. Lang chaired the Canadian Association of Emergency Physicians Conference (CAEP) 2018.